Europe’s medical devices industry saw a rise of 31.58% in cross border deal activity during November 2021, when compared with the last 12-month average, led by Coloplast ’s $2.49bn acquisition of Atos Medical , according to GlobalData’s deals database.
- Embed this chart
Embed this chart into your website
Copy and paste the image source into your website to display the chart.
A total of 25 medical devices industry cross border deals worth $2.7bn were announced for the region in November 2021, against the 12-month average of 19 deals.
Of all the deal types, M&A saw most activity in November 2021 with 14 transactions, representing a 56% share for the region.
In second place was venture financing with eight deals, followed by private equity deals with three transactions, respectively capturing a 32% and 12% share of the overall cross border deal activity for the month.
In terms of value of cross border deals, M&A was the leading category in Europe’s medical devices industry with $2.55bn, while venture financing and private equity deals totalled $114.74m and $12.73m, respectively.
Europe medical devices industry cross border deals in November 2021: Top deals
The top five medical devices cross border deals accounted for 97.8% of the overall value during November 2021.
The combined value of the top five medical devices cross border deals stood at $2.61bn, against the overall value of $2.7bn recorded for the month.
The top five medical devices industry cross border deals of November 2021 tracked by GlobalData were:
1) Coloplast $2.49bn acquisition deal with Atos Medical
2) The $49.52m acquisition of 17.8% stake in InnovHeart by Grand Pharmaceutical Group
5) 415 Capital Management,Draper Esprit,Redalpine Venture Partners,Translink Capital and Verve Capital Partners $17.5m venture financing deal with Aktiia